Hemat jouy, Shaghayegh, Lotfi, farzan, Akrami, Rahim, shahraki, jafar, Sheervalilou, Roghayeh, Shahraki, Omolbanin, Ghaznavi, Habib (2023). Investigating the Association between COVID-19 Prognosis and Demographic and Clinical Features, Underlying Diseases, and Drug and Supplement Use in Patients Hospitalized in Zabol, Iran: A Single-Center Retrospective Study. , 9(2), 167-178. doi: 10.61186/iem.9.2.167
Shaghayegh Hemat jouy; farzan Lotfi; Rahim Akrami; jafar shahraki; Roghayeh Sheervalilou; Omolbanin Shahraki; Habib Ghaznavi. "Investigating the Association between COVID-19 Prognosis and Demographic and Clinical Features, Underlying Diseases, and Drug and Supplement Use in Patients Hospitalized in Zabol, Iran: A Single-Center Retrospective Study". , 9, 2, 2023, 167-178. doi: 10.61186/iem.9.2.167
Hemat jouy, Shaghayegh, Lotfi, farzan, Akrami, Rahim, shahraki, jafar, Sheervalilou, Roghayeh, Shahraki, Omolbanin, Ghaznavi, Habib (2023). 'Investigating the Association between COVID-19 Prognosis and Demographic and Clinical Features, Underlying Diseases, and Drug and Supplement Use in Patients Hospitalized in Zabol, Iran: A Single-Center Retrospective Study', , 9(2), pp. 167-178. doi: 10.61186/iem.9.2.167
Hemat jouy, Shaghayegh, Lotfi, farzan, Akrami, Rahim, shahraki, jafar, Sheervalilou, Roghayeh, Shahraki, Omolbanin, Ghaznavi, Habib Investigating the Association between COVID-19 Prognosis and Demographic and Clinical Features, Underlying Diseases, and Drug and Supplement Use in Patients Hospitalized in Zabol, Iran: A Single-Center Retrospective Study. , 2023; 9(2): 167-178. doi: 10.61186/iem.9.2.167

Investigating the Association between COVID-19 Prognosis and Demographic and Clinical Features, Underlying Diseases, and Drug and Supplement Use in Patients Hospitalized in Zabol, Iran: A Single-Center Retrospective Study

Infection Epidemiology and Microbiology
Article 8, Volume 9, Issue 2, 2023, Pages 167-178    PDF (542.43 K)
Document Type: Original Research
DOI: 10.61186/iem.9.2.167
Authors
Shaghayegh Hemat jouy1; farzan Lotfi2; Rahim Akrami3; jafar shahraki2; Roghayeh Sheervalilou4; Omolbanin Shahraki* 4; Habib Ghaznavi4
1Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran
3Department of Epidemiology & Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Abstract
Backgrounds: The primary goal of this study was to identify the potential association between COVID-19 prognosis and demographic and clinical features, underlying diseases, and drug and supplement use in patients admitted to Amir al-Momenin hospital in Zabol.

Materials & Methods: This retrospective study surveyed the electronic health records of 848 COVID-19 patients hospitalized in a tertiary referral hospital in southeastern Iran from the beginning of the COVID-19 outbreak until the end of February 2021. Univariate and multiple analytical tests including unconditional and penalized logistic regressions were used for statistical analysis.

Findings: Out of a total of 848 patients, 371 (43.75%) patients were female, and 477 (56.25%) patients were male. Age, underlying pulmonary and cardiovascular diseases, and loss of consciousness predicted a higher mortality rate. On the contrary, a negative chest X-ray was associated with a lower risk of death.

Conclusion: Identifying predisposing factors of mortality in COVID-19 patients will help physicians provide more intensive care to those at higher risk of death by classifying patients based on risk factors and underlying diseases.
Keywords
Covid-19; Coronavirus; Infection; SARS-CoV-2; Prognosis
References
Statistics
Article View: 130
PDF Download: 71
Statistics
Number of Journals45
Number of Issues2,171
Number of Articles24,674
Article View24,465,885
PDF Download17,561,680